A report released today by the Royal College of Surgeons shows more men are getting an appropriate level of treatment, but issues with late diagnosis persist and uptake of mpMRI has been patchy. However, a pilot scheme also announced today offers a promising step forward.
Last week, Ebbsfleet United turned a flurry of social media back chat into a fundraising scheme, putting a one-off Mambo number five shirt up for auction after calls for player Yado Mambo to wear it. Now, as bidding soars, the club’s vice chairman, whose prostate cancer experience inspired the move, tells us what he hopes it will achieve.
BLOG: Having helped raise more than £200k for us since he was diagnosed with terminal prostate cancer in 2014, our incredible ambassador Kevin Webber has been chosen as the Charity Champion for this year's #GivingTuesday initiative. In this exclusive blog he describes his latest ultramarathon in the wilds of Iceland, and why helping a friend finish his own marathon challenge afterwards was worth a very painful leg.
One of the fastest-growing sports among older men, walking football is also proving popular with men recovering from cancer treatment and other health issues. So our new five-year partnership with the sport's governing body is the perfect match for everyone.
BLOG: Having grown up being silenced and marginalised as a gay man, Martin Wells was floored by another societal taboo in later life after being diagnosed with prostate cancer. He tells us how he was driven to find support and why he's delighted by our new online support group for men like him.
More news from the National Cancer Research Institute (NCRI) Cancer Conference this week comes from researchers at the Institute of Cancer Research (ICR) in London. They’ve carried out a large-scale analysis of patient data from another trial to predict which men are most likely to experience unpleasant side effects after radiotherapy.
New research presented at the National Cancer Research Institute (NCRI) Cancer Conference shows men with naturally low levels of testosterone are less likely to develop prostate cancer. But the study has also raised some difficult questions.
Our new precision medicine research programme aims to tailor treatments based on the genetic make-up of a man’s prostate cancer. The results could extend the lives of more than 9,000 men with advanced disease every year in the UK.
Hayley Yarnley knows how much our new precision medicine research programme could have helped her father, Bernie, who died from advanced prostate cancer last December. She describes how the births of her children kept him going during his treatment, and why he was convinced scientists would one day find a cure.
In this guest blog Dr Chris Armstrong – Marcher, Mo grower and ambitious researcher – explains what he hopes to achieve with the Travelling Prize Fellowship we’ve just awarded him and how this critical leg up the academic research ladder will benefit men with prostate cancer.